Global Albumin Market Size to Exceed USD 9.6 Billion By 2032 | CAGR of 4.6%
Category: HealthcareGlobal Albumin Market Size to Exceed USD 9.6 Billion by 2032
According to a research report published by Spherical Insights & Consulting, the Global Albumin Market Size is to grow from USD 6.1 Billion in 2022 to 9.6 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of 4.6% during the projected period.
Get more details on this report -
Browse key industry insights spread across 200 pages with 120 market data tables and figures & charts from the report on the "Global Albumin Market Size, Share, and COVID-19 Impact Analysis, By Product (Human Serum Albumin, Recombinant Albumin, Bovine Serum Albumin), By Application (Therapeutics, Diagnostics, Research), By End-user (Hospital & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/albumin-market
The most abundant protein in blood plasma is albumin. It is used to replace lost fluids and aid in the restoration of blood volume following trauma, burns, surgeries, infections, and liver diseases. It improves drug stability by lowering aggregation, oxidation, and surface absorption. Various types of serum albumins are widely used in clinical applications. Human serum albumin and bovine serum albumin are derived from human plasma and bovine plasma, respectively. Increased prevalence of hypoalbuminemia and other medical conditions are driving albumin market growth during the forecast period. The global demand for plasma-derived therapies, particularly albumin, has skyrocketed. This rise is primarily due to an increase in the number of cases of hypoalbuminemia caused by various life-threatening disorders, special liver diseases, infections, and cardiac surgeries. Hypoalbuminemia is characterized by decreased albumin production or increased loss of this protein through the kidneys, gastrointestinal tract, skin, or extravascular space. However, several countries have strict government regulations that limit the adoption of new products. A lack of therapeutic products, as well as stringent government regulations, impede their widespread use. Government agencies in both developed and developing countries ensure that all quality, safety, and potency criteria have been fulfilled when plasma is collected and delivered.
COVID-19 Impact
The COVID-19 outbreak is anticipated to have a positive impact on the global albumin market. The increased use of albumin for the production of vaccines such as the Covishield and Covaxin for the treatment of COVID-19 infection leads to an increase in albumin usage. According to the National Clinical Trial Registry, there are approximately ten planned and ongoing trials involving albumin for the development of COVID-19 virus vaccines. Thus, increased vaccine production increased albumin usage, which is expected to drive the albumin market during the forecast period.
The human serum albumin segment is anticipated to hold the largest share of the global albumin market over the forecast period.
Based on the product, the global albumin market is classified into human serum albumin, recombinant albumin, and bovine serum albumin. Among these, human serum albumin is expected to hold the largest share of the albumin market during the forecast period. The segmental expansion is mainly due to the introduction of new products into the market and increased sales of hypoalbuminemia-treating drugs.
The therapeutics segment will grow at a significant CAGR over the forecast period.
Based on the application, the albumin market is segmented into therapeutics, diagnostics, and research. Among these, the therapeutics segment holds the significant CAGR growth over the forecast period. The rising number of product approvals from national regulatory authorities, increased demand for albumin in R&D activities, resulting in innovative product launches, and a surge in the adoption of these products for therapeutic purposes are all contributing to segmental growth during the forecast period.
The hospital & clinics segment is witnessing substantial CAGR growth over the forecast period.
Based on the end user, the albumin market is segmented into hospitals & clinics, pharmaceutical & biotechnology industries, and research institutes. Among these, the hospital & clinics segment is expected to grow at substantial CAGR growth over the forecast period. The rise can be attributed to the increased availability of albumin-based therapeutic treatments and their administration in hospital settings.
North America dominates the market with the largest market share over the forecast period.
Get more details on this report -
North America is dominating the market share over the forecast period. Several research organizations and biopharmaceutical companies are expected to increase their investments in life sciences during the forecast period, which will likely boost the global market in the North American region. The market is expanding as a result of increased use of plasma fractionation facilities, increased R&D activities in this region, and rising albumin demand.
Europe albumin market accounts for the second-largest market share during the forecast period. The introduction of new products, the implementation of critical initiatives such as partnerships and acquisitions, and rising investments will be driving the market. The biopharmaceutical industry's expanding drug discovery and development efforts are expected to fuel the albumin market.
Asia Pacific albumin market is expected to grow at the fastest CAGR during the forecast period. This expansion can be attributed to increased government investment and research and development for technologically advanced products, which are some of the factors driving market growth in the Asia Pacific region. Furthermore, rising rates of blood-related diseases, such as blood infections, are expected to drive up demand for albumin in the coming years.
Major vendors in the global albumin market include CSL Behring (CSL), Kedrion S.p.A., Takeda Pharmaceutical Company Limited, Lazuline Bio, InVitria, Biorbyt Ltd., Grifols, S.A., Octapharma AG, Albumin Bioscience, Aspira Chemical, ALBUMEDIX, Cyagen Biosciences, Merck KGaA, Thermo Fisher Scientific Inc., and among others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In July 2023, Kedrion Biopharma, a global biopharmaceutical company that develops plasma-derived therapeutics, announced the expansion of its human serum albumin products in the Chinese market to treat rare diseases.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the global albumin market based on the below-mentioned segments:
Albumin Market, Product Analysis
- Human Serum Albumin
- Recombinant Albumin
- Bovine Serum Albumin
Albumin Market, Application Analysis
- Therapeutics
- Diagnostics
- Research
Albumin Market, End User Analysis
- Hospital & Clinics
- Pharmaceutical & Biotechnology Industry
- Research Institutes
Albumin Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?